C A Piantadosi Selected Research

C A Piantadosi Research Topics

Disease

4	Lung Injury 05/2012 - 03/2001
3	Inflammation (Inflammations) 08/2004 - 10/2001
3	Sepsis (Septicemia) 11/2001 - 05/2000
3	Acute Lung Injury 11/2001 - 03/2001
2	Decompression Sickness (Bends) 05/2008 - 01/2002
2	Hypoxia (Hypoxemia) 03/2001 - 04/2000
1	Patent Foramen Ovale 05/2008
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 07/2007
1	Osteonecrosis (Kienbock's Disease) 07/2007
1	Infections 01/2007
1	Seizures (Absence Seizure) 05/2006
1	Brain Injuries (Brain Injury) 01/2006
1	Necrosis 08/2004
1	Hyperoxia 10/2003
1	Headache (Headaches) 01/2002
1	Air Embolism (Gas Embolism) 01/2002
1	Infarction (Infarctions) 01/2002
1	Nausea 01/2002
1	Paresis (Hemiparesis) 01/2002
1	Vomiting 01/2002
1	Hyperemia 11/2001
1	Respiratory Insufficiency (Respiratory Failure) 10/2001
1	Pneumonia (Pneumonitis) 10/2001
1	Edema (Dropsy) 10/2001
1	Pulmonary Edema 10/2001
1	Reperfusion Injury 03/2001
1	Ischemia 03/2001
1	Poisoning 01/2001
1	Hepatocellular Carcinoma (Hepatoma) 10/2000
1	Granuloma 06/2000
1	Sarcoidosis (Schaumann Disease) 06/2000
1	Lung Diseases (Lung Disease) 04/2000
1	Pulmonary Alveolar Proteinosis 04/2000

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 11/2001 - 05/2000
3	Oxygen (Dioxygen)IBA 07/2007 - 11/2001
3	Interleukin-6 (Interleukin 6)IBA 11/2001 - 05/2000
3	Proteins (Proteins, Gene)FDA Link 10/2001 - 04/2000
2	Pharmaceutical PreparationsIBA 05/2012 - 10/2001
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2006 - 10/2003
2	InterleukinsIBA 08/2004 - 06/2000
2	Thromboplastin (Tissue Factor)IBA 11/2001 - 10/2001
2	FibrinIBA 11/2001 - 10/2001
2	Heme Oxygenase-1IBA 10/2001 - 04/2000
2	EnzymesIBA 10/2001 - 04/2000
2	IronIBA 03/2001 - 06/2000
2	Monoclonal AntibodiesIBA 03/2001 - 05/2000
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2001 - 05/2000
2	Interleukin-8 (Interleukin 8)IBA 06/2000 - 05/2000
1	Diphosphonates (Bisphosphonates)IBA 07/2007
1	Nuclear Respiratory FactorsIBA 01/2007
1	Transcription Factors (Transcription Factor)IBA 01/2007
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2006
1	Mitochondrial DNA (mtDNA)IBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2004
1	Protein Kinases (Protein Kinase)IBA 08/2004
1	JNK Mitogen-Activated Protein KinasesIBA 08/2004
1	Mitogen-Activated Protein KinasesIBA 08/2004
1	Protein Isoforms (Isoforms)IBA 10/2003
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 10/2003
1	Factor VIIa (Activated Factor VII)IBA 11/2001
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 11/2001
1	Fibrinogen (Factor I)FDA Link 11/2001
1	Superoxide DismutaseIBA 10/2001
1	Peroxidase (Myeloperoxidase)IBA 10/2001
1	Carbon MonoxideIBA 10/2001
1	AntioxidantsIBA 10/2001
1	thiobarbituric acidIBA 03/2001
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 03/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 03/2001
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2001
1	HEPESIBA 03/2001
1	SaltsIBA 01/2001
1	CalcineurinIBA 10/2000
1	OxalatesIBA 06/2000
1	Ferritins (Ferritin)IBA 06/2000
1	Calcium OxalateIBA 06/2000
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2000
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2000
1	L-SelectinIBA 05/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2000
1	Surface-Active Agents (Surfactants)IBA 04/2000

Therapy/Procedure

2	Therapeutics 05/2008 - 05/2000
2	Decompression 05/2008 - 01/2002
1	Mechanical Ventilators (Ventilator) 08/2004
1	Compressed Air 01/2002
1	Hyperbaric Oxygenation 01/2001
1	Treatment Delay 01/2001